A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric Adenocarcinoma
Status:
Completed
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
This prospective, randomized phase II study is designed to evaluate weather neoadjuvant
chemoradiotherapy is superior to neoadjuvant chemotherapy with both followed by surgery and
postoperative chemotherapy for locally advanced gastric adenocarcinoma.